title: Artemin has potent neurotrophic actions on injured C-fibres.
abstract: In this study, we have investigated the effects of artemin (ARTN), one of the glial cell line-derived neurotrophic factor (GDNF) family of neurotrophic factors, on C-fibres following nerve injury in the adult rat. GDNF family receptor alpha (GFRalpha) 3, the ligand binding domain of the ARTN receptor, is expressed in 34% of dorsal root ganglion (DRG) cells, predominantly in the peptidergic population of C-fibres and in a proportion of the isolectin B4 (IB4)-binding population. Interestingly, only 30% of GFRalpha3-expressing DRG cells co-expressed RET (the signal transducing domain). In agreement with previous studies, treatment with ARTN prevented many of the nerve injury-induced changes in the histochemistry of both the peptidergic and the IB4-binding populations of small, but not large, diameter DRG cells. In addition, ARTN treatment maintained C-fibre conduction velocity, and C-fibre evoked substance P release within the dorsal horn following nerve injury. ARTN was also protective following capsaicin treatment, which produces selective C-fibre injury. Given the potent neurotrophic actions of ARTN on C-fibres, it may therefore provide potential for the treatment of nerve injury, particularly in the maintenance of small fibre function.
authors.affiliation: Wolfson Centre for Age Related Disease, King's College London, Guy's Campus, London, UK. david.bennett@kcl.ac.uk
authors.forename: David L H
authors.initials: DL
authors.lastname: Bennett
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Boucher
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Michael
authors.forename: Reena J
authors.initials: RJ
authors.lastname: Popat
authors.forename: Marzia
authors.initials: M
authors.lastname: Malcangio
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Averill
authors.forename: Kris T
authors.initials: KT
authors.lastname: Poulsen
authors.forename: John V
authors.initials: JV
authors.lastname: Priestley
authors.forename: David L
authors.initials: DL
authors.lastname: Shelton
authors.forename: Stephen B
authors.initials: SB
authors.lastname: McMahon
mesh_terms: D000818:Animals; D019771:Axotomy; D002478:Cells, Cultured; D005727:Ganglia, Spinal / Q000187:drug effects / Q000293:injuries; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors / Q000378:metabolism; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D051379:Mice; D009416:Nerve Regeneration / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D009431:Neural Conduction / Q000187:drug effects; D009475:Neurons, Afferent / Q000187:drug effects* / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology; D013373:Substance P / Q000187:drug effects / Q000378:metabolism
chemical_list: C490886:ARTN protein, human; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D013373:Substance P